The field of tissue engineering seeks to create clinically effective materials for the repair of damaged tissues and organs and the treatment of medical conditions brought on by trauma, disease or congenital defects. Tissue engineering strategies involve the incorporation of novel biomaterials with biologics and/or pharmaceutics that upon implantation in the patient will stimulate angiogenesis, tissue integration, and/or tissue remodeling. This session seeks a broad range of research abstracts that encompass the various facets of development of engineered tissues. These include but are not limited to novel biomaterials, drug delivery vehicles, pharmaceutical agents, stem cell technologies, bioreactor technologies, and preliminary studies of tissue repair and healing. Tissues include but are not limited to liver, pancreas, retina, muscle, skin, tendon, cartilage, bone, vascular, and nerve. Talks involving a combination of experimental and computational approaches are strongly encouraged.
08:30 AM
Jinku Kim, Kee-Won Lee, Bradford L. Currier, Lichun Lu, Michael J. Yaszemski
08:50 AM
Elizabeth Christenson, Wafa Soofi, Neil Cameron, Antonios G. Mikos
09:10 AM
Stephanie J. Bryant, Idalis Villanueva, Garret Nicodemus
09:30 AM
Benita Comeau, Benjamin Katz, Clifford L. Henderson
09:50 AM
Edward Jan, Nicholas Kotov
10:10 AM
Vijayakumar Janakiraman, Brian Kienitz, Harihara Baskaran
10:30 AM
Yang Yang, Laura De Laporte, Marina L. Zelivyanskaya, Aileen J. Anderson, Lonnie D. Shea